Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #15,441 to #15,490.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Acute esophageal necrosis future or investigational therapies (1 revision)
  2. Acute esophageal necrosis historical perspective (1 revision)
  3. Acute esophageal necrosis history and symptoms (1 revision)
  4. Acute esophageal necrosis medical therapy (1 revision)
  5. Acute esophageal necrosis other diagnostic studies (1 revision)
  6. Acute esophageal necrosis other imaging findings (1 revision)
  7. Acute esophageal necrosis overview (1 revision)
  8. Acute esophageal necrosis pathophysiology (1 revision)
  9. Acute esophageal necrosis physical examination (1 revision)
  10. Acute esophageal necrosis prevention (1 revision)
  11. Acute esophageal necrosis risk factors (1 revision)
  12. Acute esophageal necrosis screening (1 revision)
  13. Acute esophageal necrosis surgery (1 revision)
  14. Acute esophageal necrosis x ray (1 revision)
  15. Acute hemorrhagic edema of infancy (1 revision)
  16. Acute inhalation injury (1 revision)
  17. Acute intermittant porphyria (1 revision)
  18. Acute kidney injury (patient information) (1 revision)
  19. Acute kidney injury cost-effectiveness of therapy (1 revision)
  20. Acute kidney injury future or investigational therapies (1 revision)
  21. Acute lymphoblastic leukemia case study one (1 revision)
  22. Acute lymphoblastic leukemia echocardiography (1 revision)
  23. Acute lymphoblastic leukemia echocardiography or ultrasound (1 revision)
  24. Acute megakaryoblastic leukemia case study one (1 revision)
  25. Acute megakaryoblastic leukemia cost-effectiveness of therapy (1 revision)
  26. Acute phase protein (1 revision)
  27. Acute renal failure chest x ray (1 revision)
  28. Acute respiratory distress syndrome MRI (1 revision)
  29. Acute respiratory distress syndrome case study one (1 revision)
  30. Acute retinal necrosis natural history (1 revision)
  31. Acute stress disorder comorbid conditions (1 revision)
  32. Acute stress disorder cost-effectiveness of therapy (1 revision)
  33. Acute stress disorer (1 revision)
  34. Acute stress disorer historical perspective (1 revision)
  35. Acute toxicity (1 revision)
  36. Acute tubular necrosis case study one (1 revision)
  37. Acute tubular necrosis cost-effectiveness of therapy (1 revision)
  38. Acute tubular necrosis future or investigational therapies (1 revision)
  39. Acute upper airway obstruction (patient information) (1 revision)
  40. Acute viral nasopharyngitis surgery (1 revision)
  41. Acyclic (1 revision)
  42. Acyclovir Injection (patient information) (1 revision)
  43. Acyclovir Topical (patient information) (1 revision)
  44. Acyclovir adverse reactions (1 revision)
  45. Acyclovir clinical studies (1 revision)
  46. Acyclovir contraindications (1 revision)
  47. Acyclovir description (1 revision)
  48. Acyclovir dosage and administration (1 revision)
  49. Acyclovir drug interactions (1 revision)
  50. Acyclovir how supplied (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)